Tampa, FL – At the 57th Annual Western Occupational Health Conference hosted by the Western Occupational and Environmental Medicine Association (WOEMA) September 25-28 , Robert Goldberg, MD, FACOEM, brought together fellow leaders in occupational medicine for a well-attended panel discussion on opioids and pain management.
Dr. Goldberg presented information on the size and scope of the opioid epidemic in the U.S and moderated a discussion that focused on the appropriate administration and monitoring of opioid drug therapy to achieve clinically meaningful improvement in function while minimizing risks for injured workers. Panel members Lee S. Glass, MD, and Kurt T. Hegmann, MD, MPH, provided evidence-based information about screening patients for opioid dependency risks, monitoring methods, therapy evaluation criteria and guidance on when and how to discontinue opioid therapy.
“The stakes are high for everyone when injured workers suffer painful injuries. Physicians can begin to create a better future for injured workers, their families and employers by practicing evidence-based medicine,” said Dr. Goldberg. “It was rewarding to see the audience fully engaged in the discussion.”
WOEMA is a regional component of the American College of Occupational & Environmental Medical Association (ACOEM). Dr. Goldberg is a past ACOEM president and chief medical officer at Healthesystems — a national pharmacy and ancillary benefits management provider that specializes in workers’ compensation. He was one of the original contributors to the first edition ACOEM Practice Guidelines and currently serves on the Board of Scientific Counselors and chairs the Ergonomics Committee.
Healthesystems is a WorkCompWire ad partner.
This is not a paid placement.